Support earlier, more connected cardiometabolic insight with Siemens Healthineers. Includes the first and only prognostic high-sensitivity troponin I assay available in the U.S. and the first and only blood test authorized for use as a prognostic marker in patients with advanced fibrosis due to MASH. Enable a more complete testing approach without added complexity.

Mass spectrometry is revolutionizing healthcare by providing more precise and reliable diagnostics. This innovative technology accurately measures complex biological samples, offering valuable insights to healthcare professionals. By improving diagnostic test accuracy, mass spectrometry supports better-informed decisions and more tailored, effective patient care.